The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 14, Issue -, Pages 5263-5273
Publisher
Informa UK Limited
Online
2021-11-16
DOI
10.2147/ott.s332822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decrease of peripheral blood mucosal‐associated invariant T cells and impaired serum Granzyme-B production in patients with gastric cancer
- (2021) Chunyan Shao et al. Cell and Bioscience
- Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
- (2021) Nathan D. Mathewson et al. CELL
- Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients
- (2021) William Rodin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
- (2021) Sara De Biasi et al. Nature Communications
- Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy
- (2021) Jannie Borst et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease
- (2020) Jae Kyun Ju et al. Journal of Innate Immunity
- The combined action of monocytic myeloid‐derived suppressor cells and mucosal‐associated invariant T cells promotes the progression of cervical cancer
- (2020) Zhimin Lu et al. INTERNATIONAL JOURNAL OF CANCER
- The biology and functional importance of MAIT cells
- (2019) Dale I. Godfrey et al. NATURE IMMUNOLOGY
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
- (2019) Lawrence P. Andrews et al. NATURE IMMUNOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients
- (2016) Limian Ling et al. Scientific Reports
- Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
- (2015) Luciane Zabijak et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers
- (2015) Azad Rahimpour et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ
- (2015) Patrik Sundström et al. JOURNAL OF IMMUNOLOGY
- Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
- (2013) Rangsima Reantragoon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD161-Expressing Human T Cells
- (2011) Joannah R. Fergusson et al. Frontiers in Immunology
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Antimicrobial activity of mucosal-associated invariant T cells
- (2010) Lionel Le Bourhis et al. NATURE IMMUNOLOGY
- Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
- (2010) Marielle C. Gold et al. PLOS BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started